Testicular dose and fertility in men following I131 therapy for thyroid cancer

Clinical Endocrinology - Tập 56 Số 6 - Trang 755-758 - 2002
Stephen Hyer1, L. Vini1, Mary E. O'Connell1, B. Pratt1, Clive Harmer1
1Thyroid Unit, Royal Marsden NHS Trust, Downs Road, Sutton, Surrey, UK

Tóm tắt

Summaryobjective Young adults with differentiated thyroid cancer are treated with high doses of radioiodine and have an excellent long‐term prognosis. However, there is limited information on the effects of this treatment on the gonads and fertility in male patients. We have reviewed the outcome of treatment in our centre with respect to male fertility. We have also assessed directly the radiation dose received by the testes.design Retrospective analysis of males attending the thyroid clinic at the Royal Marsden Hospital for treatment of differentiated thyroid cancer. A prospective study was also performed to assess radiation dose to testes in 14 consecutive patients attending for thyroid cancer treatment.patients Males under the age of 40 years at the time of treatment with a minimum of 3 years follow‐up.measurements Number of children fathered by patients and number of congenital malformations. For the prospective study: gonadal function assessed by serum FSH, LH and testosterone measurements; radiation dose to the testes (Gy) measured by thermoluminescent dosimetry.results Fertility was assessed in 122 men with a median follow‐up of 21 years (range 3–39) of whom 93 were under active follow‐up. One hundred and six children were fathered by 59 patients; the remainder had no wish to have children. No major malformations were reported. Of these 59 patients, 12 had received a single 3GBq ablation dose, 19 had been treated with up to 14 GBq radioiodine and 28 had received up to 44 GBq. In 14 patients followed prospectively, the median estimated radiation dose to each testis was 6·4 cGy following 3 GBq, 14·1 cGy following 5·5 GBq and 21·2 cGy following 9·2 GBq. There was a transient elevation in serum FSH after radioiodine which normalized within 9 months from the last administration.conclusions Radioiodine treatment for thyroid cancer may result in transient impairment of gonadal function. The radiation dose absorbed by the testis after a single ablative dose of radioiodine is well below that associated with permanent damage to germinal epithelium and the risk of infertility in these patients is minimal. Patients requiring multiple administrations for persistent or metastatic thyroid cancer may be at greater risk of gonadal damage although even in this group, we found no evidence of infertility.

Từ khóa


Tài liệu tham khảo

Administration of Radioactive Substances Advisory Committee (ARSAC), 2000, Notes for guidance on the clinical administration of radio‐pharmaceuticals and use of sealed radioactive sources, Nuclear Medicine Communications, 21, S1

10.1259/0007-1285-53-628-271

Baker H.W.G., 1976, Testicular control of follicle‐stimulating hormone secretion, Recent Progress in Hormone Research, 98, 997

Ceccarelli C., 2001, 131‐I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective study, Journal of Clinical Endocrinology and Metabolism, 86, 3512, 10.1210/jcem.86.8.7719

Dottorini M.E., 1995, Assessment of female fertility and carcinogenesis after iodine‐131 therapy for differentiated thyroid carcinoma, Journal of Nuclear Medicine, 36, 21

10.1136/bmj.281.6254.1527

10.1111/j.1365-2265.1983.tb02876.x

Harper P.S., 1998, Practical Genetic Counselling

Haynie T.P., 1995, How safe for the patient is iodine‐131 for differentiated thyroid cancer?, Journal of Nuclear Medicine, 36, 27

10.1002/1097-0142(19820601)49:11<2281::AID-CNCR2820491113>3.0.CO;2-1

10.1016/S0889-8529(18)30317-7

10.1016/0002-9343(94)90321-2

10.1210/jcem.86.4.7407

MIRD., 1975, Dose estimate report no. 5, Journal of Nuclear Medicine, 16, 857

Pacini F., 1994, Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine, Journal of Nuclear Medicine, 35, 1418

Planskoy B., 1983, Radiation Therapy Planning, 14

Schlumberger M., 1996, Exposure to radioactive iodine‐131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients, Journal of Nuclear Medicine, 37, 606

10.1200/JCO.1985.3.9.1232

10.1210/jcem-10-9-1007

10.1002/1097-0142(19850215)55:4<794::AID-CNCR2820550418>3.0.CO;2-Z

Vini L., 1998, In vivo dosimetry of radioiodine in patients with metastatic differentiated thyroid carcinoma, European Journal of Nuclear Medicine, 25, 904

10.1136/pmj.78.916.92

10.1007/978-1-59259-199-2

10.1007/s002590050535

Thông tin
Thông tin xuất bản

Clinical Endocrinology

Tập 56 Số 6

755-758

Thông tin tác giả